Methanex Corp (MX):企業の財務・戦略的SWOT分析

◆英語タイトル:Methanex Corp (MX) - Financial and Strategic SWOT Analysis Review
◆商品コード:SWOT20MY0377
◆発行会社(調査会社):GlobalData
◆発行日:2019年12月
◆ページ数:50
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:カナダ
◆産業分野:Chemicals
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥18,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥55,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Methanex Corp (MX) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Methanex Corp (Methanex) is a chemical company that carries out production, marketing and supply of methanol, a clean-burning, cost-effective alternative fuel. It operates through an extensive global supply chain and distribution network of terminals and storage facilities. The company holds marketing rights for production from jointly-owned plants in Trinidad and Egypt. It caters to diverse industries including resins, plastics, and paints, building materials, foams, polyester and pharmaceutical. Methanex has production sites in New Zealand, the US, Trinidad, Egypt, Canada and Chile. The company has operations in major markets across North America, Asia Pacific, Europe and South America. Methanex is headquartered in Vancouver, British Columbia, Canada.

Methanex Corp Key Recent Developments

Oct 30,2019: Methanex Reports Third Quarter 2019 Results
Oct 11,2019: Gov. Edwards Highlights Latest Methanex Project Underway in Louisiana
Oct 08,2019: Methanex Reaches Agreement for Natural Gas Supply to Its Chile Operations
Oct 05,2019: NYK announces Low Emission Methanol-Fueled Chemical Tanker Delivered
Sep 18,2019: Air Liquide Announces Significant Investment in U.S. Gulf Coast to Support New Long-term Agreement With Methanex

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Methanex Corp – Key Facts
Methanex Corp – Key Employees
Methanex Corp – Key Employee Biographies
Methanex Corp – Major Products and Services
Methanex Corp – History
Methanex Corp – Company Statement
Methanex Corp – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Joint Venture
Section 2 – Company Analysis
Company Overview
Methanex Corp – Business Description
Methanex Corp – Corporate Strategy
Methanex Corp – SWOT Analysis
SWOT Analysis – Overview
Methanex Corp – Strengths
Methanex Corp – Weaknesses
Methanex Corp – Opportunities
Methanex Corp – Threats
Methanex Corp – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Petrochemicals Financial Deals and Alliances
Methanex Corp, Petrochemicals, Deals By Year, 2013 to YTD 2019
Methanex Corp, Petrochemicals, Deals By Type, 2013 to YTD 2019
Methanex Corp, Recent Deals Summary
Section 5 – Company’s Recent Developments
Oct 30, 2019: Methanex Reports Third Quarter 2019 Results
Oct 11, 2019: Gov. Edwards Highlights Latest Methanex Project Underway in Louisiana
Oct 08, 2019: Methanex Reaches Agreement for Natural Gas Supply to Its Chile Operations
Oct 05, 2019: NYK announces Low Emission Methanol-Fueled Chemical Tanker Delivered
Sep 18, 2019: Air Liquide Announces Significant Investment in U.S. Gulf Coast to Support New Long-term Agreement With Methanex
Sep 10, 2019: Johnson Matthey’s latest ATR technology licence underway after Methanex reaches final investment decision for Geismar 3 plant
Aug 22, 2019: Waterfront Shipping adds two new methanol-fuelled vessels to its fleet
Jul 31, 2019: Methanex reports second quarter 2019 results
Jul 29, 2019: Methanex appoints Kevin Rodgers to its Board of Directors
Jul 26, 2019: KBR to start EPC phase of Methanex’s Geismar 3 methanol project
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Methanex Corp, Key Facts
Methanex Corp, Key Employees
Methanex Corp, Key Employee Biographies
Methanex Corp, Major Products and Services
Methanex Corp, History
Methanex Corp, Other Locations
Methanex Corp, Subsidiaries
Methanex Corp, Joint Venture
Methanex Corp, Key Competitors
Methanex Corp, Ratios based on current share price
Methanex Corp, Annual Ratios
Methanex Corp, Annual Ratios (Cont...1)
Methanex Corp, Annual Ratios (Cont...2)
Methanex Corp, Interim Ratios
Methanex Corp, Petrochemicals, Deals By Year, 2013 to YTD 2019
Methanex Corp, Petrochemicals, Deals By Type, 2013 to YTD 2019
Methanex Corp, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
Methanex Corp, Performance Chart (2014 - 2018)
Methanex Corp, Ratio Charts
Methanex Corp, Petrochemicals, Deals By Year, 2013 to YTD 2019
Methanex Corp, Petrochemicals, Deals by Type, 2013 to YTD 2019

★海外企業調査レポート[Methanex Corp (MX):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • NightstaRx Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary NightstaRx Ltd (NightstaRx) a subsidiary of Nightstar Therapeutics PLC is a clinical-stage gene therapy company that engaged in developing and commercializing novel. The company also involved in providing one-time treatments for patients suffering from rare inherited retinal diseases. It pro …
  • Aliancys AG:企業の戦略的SWOT分析
    Aliancys AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Syngenta AG:企業の戦略的SWOT分析
    Syngenta AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • miacom diagnostics GmbH-医療機器分野:企業M&A・提携分析
    Summary miacom diagnostics GmbH (miacom) is a molecular diagnostic company that develops and distributes molecular diagnostic tests. The company offers products such as hemoFISH, which identifies sepsis-related pathogens directly from positive blood culture bottles; respiFISH that identifies pathoge …
  • Donaldson Company, Inc.:企業の戦略・SWOT・財務分析
    Donaldson Company, Inc. - Strategy, SWOT and Corporate Finance Report Summary Donaldson Company, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Vallourec Sa:企業の戦略・SWOT・財務分析
    Vallourec Sa - Strategy, SWOT and Corporate Finance Report Summary Vallourec Sa - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Abivax SA (ABVX):企業の財務・戦略的SWOT分析
    Summary Abivax SA (Abivax) is a biotechnology company that develops and commercializes anti-viral therapies and therapeutic vaccines for the treatment of infectious and viral diseases. The company’s pipeline products include ABX464, ABX544 and ABX196. Its ABX464 is an oral small molecule to induce f …
  • Williams Industrial Services Group Inc (WLMS):企業の財務・戦略的SWOT分析
    Summary Williams Industrial Services Group Inc (Williams), formerly Global Power Equipment Group Inc, is a provider of custom-engineered auxiliary equipment and maintenance support services. The company offers products such as control houses, gas and steam turbine auxiliary products, and generator e …
  • Meritor, Inc. (MTOR):企業の財務・戦略的SWOT分析
    Meritor, Inc. (MTOR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Blueprint Medicines Corp (BPMC)-医療機器分野:企業M&A・提携分析
    Summary Blueprint Medicines Corp (Blueprint) is a biotechnology company that develops drugs for the treatment of cancers. The company discovers selective kinase inhibitors for genomically defined cancer subsets. Its pipeline products include BLU-285, for treatment resistant gastrointestinal stromal …
  • Schroders plc:戦略・SWOT・企業財務分析
    Schroders plc - Strategy, SWOT and Corporate Finance Report Summary Schroders plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • St. George’s University of London:製薬・医療:M&Aディール及び事業提携情報
    Summary St. George's University of London (SGUL), a subsidiary of University of London is a medical and healthcare education provider. It offers undergraduate and post graduate courses. The university’s undergraduate courses include biomedical science BSc, healthcare practice DipHE and BSc, healthca …
  • Suncor Energy Inc.:企業の戦略・SWOT・財務情報
    Suncor Energy Inc. - Strategy, SWOT and Corporate Finance Report Summary Suncor Energy Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Mid-America Apartment Communities Inc (MAA):企業の財務・戦略的SWOT分析
    Summary Mid-America Apartment Communities Inc (MAA) is a real estate investment company that operates apartment homes. The company is engaged in property development, property management, redevelopment, acquisition, sales, marketing and financing. MAA provides web-based and technology driven support …
  • Relief Therapeutics Holding AG (RLF):企業の財務・戦略的SWOT分析
    Summary Relief Therapeutics Holding AG (Relief Therapeutics) is a drug development company that offers clinical development of peptides and proteins of natural or engineered origin. The company’s pipeline drug candidates include aviptadil for the treatment of sarcoidosis and low dose interleukin-6 t …
  • Nan Ya Plastics Corp (1303):企業の財務・戦略的SWOT分析
    Nan Ya Plastics Corp (1303) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Epigenomics AG (ECX):製薬・医療:M&Aディール及び事業提携情報
    Summary Epigenomics AG (Epigenomics) is a molecular diagnostics company which develops and commercializes in-vitro diagnostic (IVD) tests for screening, early detection and diagnosis of cancer. Its lead product, Epi proColon is a blood-based test for rapid detection of colorectal cancer; and Epi pro …
  • TDC AS (TDC):企業の財務・戦略的SWOT分析
    TDC AS (TDC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pote …
  • SP Transmission plc:企業の戦略的SWOT分析
    SP Transmission plc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • POSCO:企業のM&A・事業提携・投資動向
    POSCO - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's POSCO Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisin …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆